Key result
Body surface mapping provides a more comprehensive electrocardiographic data set than the conventional 12-lead ECG and can potentially detect and display transient regional myocardial ischemia.
Why the study?
Does body surface mapping improve the detection of transient myocardial ischemia compared to conventional 12-lead ECG in patients with suspected angina?
Does body surface mapping improve the detection of transient myocardial ischemia compared to conventional 12-lead ECG in patients with suspected angina?
Body surface mapping is a promising technique that may provide more comprehensive diagnostic data than the 12-lead ECG for detecting transient myocardial ischemia.
May support evaluation of body surface mapping for ischemia detection in angina; leaves open clinical superiority over 12-lead ECG.
Coronary artery disease (CAD) is one of the leading causes of cardiovascular mortality and morbidity worldwide. CAD presents as a wide spectrum of clinical disease from stable angina to ST segment elevation myocardial infarction. The 12-lead electrocardiogram (ECG) has been the main tool for the diagnosis of these events for almost a century but is limited in its diagnostic ability. For patients with suspected angina, the exercise tolerance test is often used to provoke and detect stress-induced ischemia but does not provide a definitive answer in a substantial proportion of patients. Body surface mapping (BSM) is a technique that samples multiple points around the thorax to provide a more comprehensive electrocardiographic data set than the conventional 12-lead ECG. Moreover, recent preliminary data demonstrate that BSM can detect and display transient regional myocardial ischemia in an intuitive fashion, employing subtraction color mapping, making it potentially valuable for diagnosing CAD causing transient regional ischemia. Research is ongoing to determine the full extent of its utility.
No takes yet. Share an insight, caveat, or question.
Monique Robinson (2009) conducted a review in Coronary artery disease. Body surface mapping (BSM) vs. 12-lead ECG was evaluated. Body surface mapping provides a more comprehensive electrocardiographic data set than the conventional 12-lead ECG and can potentially detect and display transient regional myocardial ischemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: